Targeting white matter astrocytes with a Gfap-disruptive Cas9 nuclease benefits a murine model of Alexander disease.

Hillen AEJ, Capuano I, Gega B, Norata R, Mombled M, Laface I, Zambonini G, Lomagno A, Rouillon M, Giannelli SG, et al.